Search for company
Explore more than 1.3 million company profiles from emerging markets

NGL Fine - Chem Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Quote Chart
Quote Summary
Last Price 214.00
Volume 3,797
Turnover 806,863
Market Madras Stock Exchange
Ticker 524774
Market Cap Market Cap 1,322,097
52 Week High 241.50
52 Week Low 43.75
P/E 15.87
EPS 13.48
Dividend Yield
Bookvalue 553,556
Enterprise Value 495,391
Quote updated on October 09, 2015
Note: data in INR Thousands.
Select Items to chart them. 2016 Q1
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets N/A
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Individual
Source: Dion Global Solutions Limited, EMIS Company Database.
Company Description

NGL Fine-Chem Ltd. engages as a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. The company was incorporated in the year 1981 and has its headquarters based in Navi Mumbai.

Main Products

Tablets, Drugs Bulk & Intermediates, Finished Goods,

Contact Information

Legal Address
W-142 (C),, TTC MIDC Industrial Area, Pawane Village
Navi Mumbai; Maharashtra; Map
Postal Code: 400705
Tel: 27630547
Fax: 40539900

Full name: NGL Fine - Chem Ltd.

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
IN-CIN: L24110MH1981PLC025884
ISIN Code: INE887E01022
Incorporation Date: 1981

Basic Information
Outstanding Shares:
: ()
Registered Capital:
Financial Auditors:
2013: Imports INR 111,850.26 Thousands
Import connections ('000)
2013: Exports INR 392,247.17 Thousands
Export connections ('000)
Key Executives
Compliance Officer
Ownership Details
Indian Promoters
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - India

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.